resources

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA

BSE: 524715

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,902.40-1.6 (-0.08%)

21 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Sun Pharmaceutical Industries Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	—	Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	2Jun 6Aug 11Nov	3Feb 2Jun 3Aug 5Nov	1Feb 31May 9Aug 8Nov	29May 7Aug 4Nov	6Feb 29May 6Aug 11Nov	4Feb 5May 29May 6Aug
Presentations	—	—	—	—	—	—	—	—	—	24Mar 16Sept	16Jan 28Apr 21Jul 11Sept	14Mar 10Jul 30Sept 28Nov	4Mar 14Jul 1Sept 26Dec	24Feb 27Apr 7Jul

Corporate Announcements and Regulatory Filings

Sun Pharmaceutical Industries Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General17 Aug 2026
Update On Lipitor Antitrust Litigation
Update on Lipitor Antitrust Litigation
General6 Aug 2026
Receipt Of No-Objection Letters From The Stock Exchanges For Reclassification Of Promoter Group
Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group
Analyst / Investor Meet5 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor Meeting
Credit Rating5 Aug 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Update on Credit Rating
Newspaper Publication1 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement
General31 Jul 2026
Voting Results And Scrutinizer Report Of 34Th AGM Held On 31 July 2026
Voting Results for 34th AGM
AGM31 Jul 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of the 34th Annual General Meeting held on 31 July 2026
General31 Jul 2026
Q1FY27-Investor Call Audio Recording
SPIL Q1FY27-Investor Call Audio Recording
General31 Jul 2026
Conclusion Of The Board Meeting Held Today, I.E., 31 July 2026
Conclusion of the Board Meeting held today
Press Release / Media Release29 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma receives approval to manufacture and market semaglutide in Brazil
General27 Jul 2026
Update On Nidlegy
Update on Nidlegy
Press Release / Media Release24 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma notes Organon Shareholder approval for proposed acquisition
Press Release / Media Release15 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release
Analyst / Investor Meet14 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharma to announce first quarter results on 31 July 2026 Earnings call scheduled on Friday, 06.30 pm IST, 31 July 2026
Board Meeting10 Jul 2026
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026
Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Unaudited Standalone ....
Newspaper Publication7 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Confirmation Certificate for the quarter ended 30 June 2026.
AGM6 Jul 2026
Notice Of 34Th Annual General Meeting To Be Held On 31 July 2026 Along With The Annual Report For FY 2025-26
Notice of 34th Annual General Meeting along with the Annual Report for FY 2025-26
Reg. 34 (1) Annual Report6 Jul 2026
Reg. 34 (1) Annual Report.
Annual Report 2025-26 and the Notice of 34th Annual General Meeting
Newspaper Publication26 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement

Frequently Asked Questions

Where can I download the annual report of Sun Pharmaceutical Industries Ltd.?

Annual reports of Sun Pharmaceutical Industries Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Sun Pharmaceutical Industries Ltd.?

Quarterly earnings results and presentations of Sun Pharmaceutical Industries Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Sun Pharmaceutical Industries Ltd. publish earnings call transcripts?

Earnings call transcripts of Sun Pharmaceutical Industries Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Sun Pharmaceutical Industries Ltd.?

Investor presentations and annual day presentations of Sun Pharmaceutical Industries Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Sun Pharmaceutical Industries Ltd.?

Corporate announcements and regulatory filings of Sun Pharmaceutical Industries Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Sun Pharmaceutical Industries Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sun Pharmaceutical Industries Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Sun Pharmaceutical Industries Ltd.?

The ISIN (International Securities Identification Number) of Sun Pharmaceutical Industries Ltd. is INE044A01036. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Sun Pharmaceutical Industries Ltd. listed?

Sun Pharmaceutical Industries Ltd. is listed on NSE and BSE. The NSE symbol is SUNPHARMA and the BSE code is -.

Where can I find the shareholding pattern of Sun Pharmaceutical Industries Ltd.?

The quarterly shareholding pattern of Sun Pharmaceutical Industries Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Sun Pharmaceutical Industries Ltd. on Sharpely?

Share price data for Sun Pharmaceutical Industries Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.